title: Reply to Letter: "Response to Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?".
authors.affiliation: Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital Amsterdam, The Netherlands.
authors.forename: Mila
authors.initials: M
authors.lastname: Donker
authors.forename: Emiel E Th
authors.initials: EE
authors.lastname: Rutgers
authors.forename: Marie-Jeanne T F D
authors.initials: MJ
authors.lastname: Vrancken Peeters
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals